No profile data available.
Soligenix, Inc. (SNGX) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Princeton, United States, with about 13 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$11.08 million. Its market capitalization was $7.91 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. The company operates through two segments, Specialized BioTherapeutics and Public Health Solutions.
Soligenix reported $0 in revenue for fiscal year 2025.
$7.91 million as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Theriva Biologics, Inc. (TOVX), Senti Biosciences, Inc. (SNTI), Mangoceuticals, Inc. (MGRX), Longeveron Inc. (LGVN).